Impact BioMedical Inc.
IBO
$0.55
-$0.03-5.64%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -98.48% | -99.85% | -99.55% | 31,100.00% | 65,800.00% |
| Total Receivables | -2.45% | 10.33% | 50.70% | -23.95% | -38.37% |
| Inventory | -87.12% | -- | -- | -- | -- |
| Prepaid Expenses | -44.77% | -46.77% | -43.56% | 307.14% | 8,500.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 0.00% | -- | -- | -- |
| Total Current Assets | -82.73% | -83.21% | -71.12% | 382.41% | 551.64% |
|
|
|||||
| Total Current Assets | -82.73% | -83.21% | -71.12% | 382.41% | 551.64% |
| Net Property, Plant & Equipment | -- | -- | -95.39% | -95.07% | -94.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -6.40% | -4.57% | -4.47% | -4.36% | -4.24% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -14.79% | -14.22% | -61.01% | -56.80% | -54.80% |
|
|
|||||
| Total Accounts Payable | -39.19% | 10.51% | -42.46% | -43.81% | -39.88% |
| Total Accrued Expenses | -3.23% | 0.00% | 229.41% | 336.07% | 361.70% |
| Short-term Debt | -- | -- | -- | 66.16% | -28.51% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 55.64% | -- | -- | -- |
| Total Other Current Liabilities | -- | 55.64% | -- | -- | -- |
| Total Current Liabilities | -83.08% | -88.12% | 1,990.77% | 59.82% | -28.03% |
|
|
|||||
| Total Current Liabilities | -83.08% | -88.12% | 1,990.77% | 59.82% | -28.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 66.16% | -28.51% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -78.95% | -78.95% | 1.02% | 1.02% | 1.02% |
| Total Liabilities | -82.06% | -85.83% | 119.22% | 49.09% | -22.53% |
|
|
|||||
| Common Stock & APIC | 48.08% | 48.36% | 2.47% | 12.48% | 12.06% |
| Retained Earnings | -33.02% | -31.43% | -418.44% | -259.78% | -179.65% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 203.04% | 200.29% | -137.93% | -144.61% | -84.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 203.04% | 200.29% | -137.93% | -144.61% | -84.37% |
| Total Preferred Equity | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | 9.44% | -1.07% | -1.57% | -1.60% | -1.23% |
| Total Equity | 116.02% | 114.94% | -125.77% | -127.97% | -75.02% |
|
|
|||||